Driving Pressure During General Anesthesia for Minimally Invasive Abdominal Surgery (GENERATOR)
- Conditions
- SurgeryPostoperative Complications
- Interventions
- Procedure: Intraoperative ventilation with individualized high PEEP titrated to the lowest ΔP with RMs
- Registration Number
- NCT06101511
- Brief Summary
The purpose of this international multicenter, patient and outcome-assessor blinded randomized controlled trial is to determine whether the application of an individualized high Positive End Expiratory Pressure (PEEP) strategy with recruitment maneuvers, aiming at avoiding an increase in the driving pressure during intraoperative ventilation, protects against the development of postoperative pulmonary complications in patients undergoing minimally invasive abdominal surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1806
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Individualized high PEEP strategy with recruitment maneuvers Intraoperative ventilation with individualized high PEEP titrated to the lowest ΔP with RMs The intervention is intraoperative ventilation using the available ventilator with individualized high positive end-expiratory pressure (PEEP) titrated to the lowest driving pressure (ΔP) with recruitment maneuvers (RMs). After abdominal insufflation, patients randomized to the individualized high PEEP with RMs group will receive a RM followed by a 'decremental PEEP trial'. This is followed by a second RM after which PEEP is set at the level indicated by the decremental PEEP trial.
- Primary Outcome Measures
Name Time Method Proportion of participants developing one or more postoperative pulmonary complications (PPCs) The first 5 postoperative days A composite of the following pulmonary complications: mild respiratory failure; severe respiratory failure; bronchospasm; suspected pulmonary infection; pulmonary infiltrate; aspiration pneumonitis; atelectasis; acute respiratory distress syndrome (ARDS); pleural effusion; cardiopulmonary edema; pneumothorax
- Secondary Outcome Measures
Name Time Method Intraoperative complications For the duration of general anesthesia, these outcomes are scored every hour up to a maximum of 18 hours Including: any episode of desaturation; any episode of hypotension; any need for vasoactive agents, either as bolus or continuous administration, defined as more than needed to compensate for vasodilating effects of anesthesia as judged by the attending anesthesiologist and any new arrhythmias needing intervention
Intraoperative fluid strategy During general anesthesia Including the total amount of fluids administered during anesthesia, including the amounts of colloids, crystalloids, and blood products
Antibiotics use The first 5 postoperative days Use of antibiotics for pneumonia (proportion of patients who received antibiotics)
Length of stay Postoperatively until the end of the 90 day follow-up period Length of hospital stay (days); length of ICU admission if applicable (days);
Thoracic imaging The first 5 postoperative days Occurence of imaging (chest X-ray, computed tomography scan). Proportion of patients who underwent thoracic imaging.
Oxygen use The first 5 postoperative days Postoperative supplemental oxygen use (days). Presence, duration and levels of postoperative supplemental oxygen
Impaired wound healing The first 5 postoperative days Impaired wound healing, as judged and mentioned in the medical record by the attending ward physician;
Postoperative extrapulmonary complications The first 5 postoperative days Including: sepsis; septic shock; extrapulmonary infection; anastomotic leak and acute renal failure
Mortality Postoperative day 5, day 30 and day 90 All-cause mortality at day 5, day 30 and 90, and in-hospital mortality
Trial Locations
- Locations (1)
Amsterdam University Medical Center
🇳🇱Amsterdam, Noordholland, Netherlands